RA Capital
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$931.9M
Focus Areas
9
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| ARS Pharmaceuticals | $736.8M |
| Karyopharm Therapeutics | $195.1M |
| Enara Bio | — |
| Stylus Medicine | — |
| Nimbus Therapeutics | — |
| AryoGen Pharmed | — |